Bright Green Corporation is a biotechnology company specializing in the cultivation and production of cannabis for medicinal and research purposes
The company focuses on advancing the science of cannabis by leveraging state-of-the-art cultivation techniques and cutting-edge research to deliver high-quality, compliant products. Bright Green aims to support the healthcare industry by providing access to safe and effective cannabis treatments while also exploring new applications in various therapeutic areas. The organization is committed to sustainable practices and adheres to stringent regulatory standards to ensure the integrity and efficacy of its offerings.
FORT LAUDERDALE, FLORIDA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright Green” or the “Company”) announced that on February 24, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the “RSA” Restructuring Security Agreement. The highlights of the RSA will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution.
RJD Green Inc. (OTC: RJDG) captured significant investor attention, leading to a substantial stock gain of 29.5% on June 5, 2024. The trading volume surged to nine times the average daily volume. The company announced that its business unit, Silex Holdings Inc., achieved its highest monthly revenue since its establishment in June 2006. In May, Silex Holdings, Inc., a division of RJD Green, recorded $865,730 in revenues and a net operating profit of $242,404 . For context, the average annual revenue from Silex over the past two years was $4,800,000, with May 2024 revenues accounting for 18.1% of the annual income in 2023.
GRANTS, N.M., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of the few companies selected by the U.S. government to grow, manufacture, and sell, legally under both federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that specific plants have now been selected for the test crops at its Grants New Mexico facility, and the company gives its operational updates.
The Company plans to foster relationships with learning institutes across the U.S. to enhance the application of scientific discipline to the field of medical and pharmaceutical cannabinoid therapies and to build upon this unique EB-5 initiative for capital moving forward.
The Company views the development as an additional milestone building on its key strategic achievement in 2023 already including its historic DEA registration and confirmation of its EB-5 program.
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against RH (NYSE: RH), Hayward Holdings, Inc. (NYSE: HAYW), Bright Green Corporation (NASDAQ: BGXX), and Veradigm, Inc. (NASDAQ: MDRX). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Bright Green (NASDAQ: BGXX) is one of the few companies selected by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. The company recently announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,684,210 shares of common stock and warrants to purchase up to 3,684,210 shares of common stock, at a purchase price of $0.95 per share and accompanying warrant. Bright Green expects approximately $3.5 million in gross proceeds from the private placement. EF Hutton, division of Benchmark Investments LLC, is acting as the exclusive placement agent for the offering.
Bright Green (NASDAQ: BGXX) is one of the few companies selected by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. The company recently announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,684,210 shares of common stock and warrants to purchase up to 3,684,210 shares of common stock, at a purchase price of $0.95 per share and accompanying warrant. Bright Green expects approximately $3.5 million in gross proceeds from the private placement. EF Hutton, division of Benchmark Investments LLC, is acting as the exclusive placement agent for the offering.
GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, today announced the closing of its previously announced private placement of common stock and warrants.
Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval.
GRANTS, N.M., May 22, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,684,210 shares of common stock and warrants to purchase up to 3,684,210 shares of common stock, at a purchase price of $0.95 per share and accompanying warrant. The gross proceeds to the Company from the private placement are expected to be approximately $3.5 million before deducting the placement agent's fees and other estimated offering expenses.
Bright Green, the first publicly traded company in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical and medical applications, can qualify for the EB-5 program and plans to raise $500 million in new capital
Bright Green is now the first publicly traded company, and the largest, in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical applications and affiliated import and export
San Diego, CA -- (SBWIRE) -- 04/19/2023 -- Bright Green Corporation is under investigation over potential securities laws violations in connection with certain financial statements .
Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FTX Tokens (CCC: FTT), G-III Apparel Group, Ltd. (NASDAQ: GIII), Bright Green Corporation (NASDAQ: BGXX), and Consensus Cloud Solutions, Inc. (NASDAQ: CCSI). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz announces an investigation of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public.
